You are here

  • Home
  • Archive
  • Volume 7, Issue 9
  • Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali

Responses

Article menu

Download PDFPDF

XML
Obstetrics and gynaecology
Research
Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 15 October 2017
    Critical analysis of the Dumont et al. uterine balloon randomized controlled trial in Benin and Mali
    • Thomas F. Burke, Physician and Professor Massachusetts General Hospital and Harvard University

    As postpartum hemorrhage (PPH) researchers, and leaders in education and care of maternal health emergencies, from the United States, UK, Canada, India, Peru, Honduras, Zambia, India, Kenya, Tanzania, Colombia and Nepal, we read the Dumont et al paper with great interest. We would like to share our review:

    The most fundamental flaw of this paper is that the authors confuse an intention-to-treat study of a clinical pathway of interventions and behaviors, with the efficacy of a device. These are two very different research questions. In order to test the latter via a randomized controlled trial (RCT) the two groups would need to be the similar and subjects that did not even receive the device (or received it in desperation two hours after the diagnosis of uncontrolled PPH) certainly could not be included in the intervention group. Thus, this study attempts to test intention-to-treat, not the efficacy of the uterine balloon tamponade (UBT) device.

    The second most obvious flaw is that degrees of illness are not accounted for. Clinically defined "uncontrolled PPH" is in no way a homogeneous group. For example, someone that has been referred in and is moribund from their advanced shock is an entirely different subject than someone who has mild uncontrolled PPH. Since this is not controlled for, these two groups are likely incomparable.

    Even taking into account the two issues described above, the two groups are different and heavily favor the non-...

    Show More
    Conflict of Interest:
    None declared.